Discovery and initial characterization of Th9 cells: the early years

Seminars in Immunopathology

Volumn 39, Issue 1, 2017, Pages 5-10

  Schmitt, Edgar ^a   Bopp, Tobias ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cytokine; IL 9; T helper cell; T lymphocyte differentiation; Th9

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

CD4+ T LYMPHOCYTE; CELL MATURATION; COLITIS; CYTOKINE PRODUCTION; HUMAN; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MEDICAL RESEARCH; MOLECULAR CLONING; NEURITIS; NONHUMAN; PERIPHERAL NERVE INJURY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; TH9 CELL; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HELPER CELL; HISTORY; IMMUNOLOGY; METABOLISM; MOUSE; RESEARCH; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CLONING, MOLECULAR; CYTOKINES; GENE EXPRESSION REGULATION; HISTORY, 20TH CENTURY; HUMANS; INTERLEUKIN-9; MICE; RECEPTORS, INTERLEUKIN-9; RESEARCH; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84997769473     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-016-0610-0     Document Type: Review

References (44)

1. Miller JFAP (2011) The golden anniversary of the thymus. Nat Rev Immunol 11:489–495. doi:10.1038/nri2993
2. Mosmann TR, Cherwinski H, Bond MW et al (1986) Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357
3. Cherwinski H, Schumacher J, Brown K, Mosmann T (1987) Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 166:1229–1244
4. Cher DJ, Mosmann TR (1987) Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138:3688–3694
5. Uyttenhove C, Simpson RJ, Van Snick J (1988) Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proceedings of the National Academy of Sciences of the United States of America 85:6934–6938.
6. Van Snick J, Goethals A, Renauld JC et al (1989) Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med 169:363–368
7. Spaeth E, Rude E (1985) Development of T cell clones reactive to two defined restriction elements in conjunction with two defined epitopes of antigen. Eur J Immunol 15:1177–1183. doi:10.1002/eji.1830151207
8. Schmitt E, van Brandwijk R, Van Snick J et al (1989) TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur J Immunol 19:2167–2170
9. Hultner L, Moeller J, Schmitt E et al (1989) Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. J Immunol 142:3440–3446
10. Moeller J, Hultner L, Schmitt E, Dormer P (1989) Partial purification of a mast cell growth-enhancing activity and its separation from IL-3 and IL-4. J Immunol 142:3447–3451
11. Hultner L, Druez C, Moeller J et al (1990) Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 20:1413–1416
12. Yang YC, Ricciardi S, Ciarletta A et al (1989) Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. Blood 74:1880–1884
13. Druez C, Coulie P, Uyttenhove C, Van Snick J (1990) Functional and biochemical characterization of mouse P40/IL-9 receptors. J Immunol 145:2494–2499
14. Renauld JC, Druez C, Kermouni A, et al. (1992) Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proceedings of the National Academy of Sciences of the United States of America 89:5690–5694
15. Kimura Y, Takeshita T, Kondo M et al (1995) Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int Immunol 7:115–120
16. Malka Y, Hornakova T, Royer Y et al (2008) Ligand-independent homomeric and heteromeric complexes between interleukin-2 or −9 receptor subunits and the gamma chain. J Biol Chem 283:33569–33577. doi:10.1074/jbc.M803125200
17. Demoulin JB, Uyttenhove C, Van Roost E et al (1996) A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol Cell Biol 16:4710–4716
18. Knoops L, Renauld J-C (2004) IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22:207–215. doi:10.1080/08977190410001720879
19. Renauld JC, Goethals A, Houssiau F et al (1990) Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene. J Immunol 144:4235–4241
20. Houssiau FA, Renauld JC, Fibbe WE, Van Snick J (1992) IL-2 dependence of IL-9 expression in human T lymphocytes. J Immunol 148:3147–3151
21. Houssiau FA, Schandene L, Stevens M et al (1995) A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J Immunol 154:2624–2630
22. Seibert FB, Pedersen KO, Tiselius A (1938) Molecular weight, electrochemical and biological properties of tuberculin protein and polysaccharide molecules. J Exp Med 68:413–438. doi:10.1084/jem.68.3.413
23. Schmitt E, van Brandwijk R, Fischer HG, Rude E (1990) Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors. Eur J Immunol 20:1709–1715
24. Schmitt E, Beuscher HU, Huels C et al (1991) IL-1 serves as a secondary signal for IL-9 expression. J Immunol 147:3848–3854
25. Brabletz T, Pfeuffer I, Schorr E et al (1993) Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol 13:1155–1162
26. Siepl C, Bodmer S, Frei K et al (1988) The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor. Eur J Immunol 18:593–600. doi:10.1002/eji.1830180416
27. Schmitt E, Germann T, Goedert S et al (1994) IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 153:3989–3996
28. Gessner A, Blum H, Rollinghoff M (1993) Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189:419–435. doi:10.1016/S0171-2985(11)80414-6
29. Sad S, Mosmann TR (1994) Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 153:3514–3522
30. Chen W, Jin W, Hardegen N et al (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886
31. Fantini MC, Becker C, Monteleone G et al (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172:5149–5153. doi:10.4049/jimmunol.172.9.5149
32. Lu L-F, Lind EF, Gondek DC et al (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997–1002
33. Awasthi A, Carrier Y, Peron JPS et al (2007) A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells. Nat Immunol 8:1380–1389. doi:10.1038/ni1541
34. Stumhofer JS, Silver JS, Laurence A et al (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8:1363–1371. doi:10.1038/ni1537
35. Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238. doi:10.1038/nature04753
36. Veldhoen M, Hocking RJ, Atkins CJ et al (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189. doi:10.1016/j.immuni.2006.01.001
37. Veldhoen M, Uyttenhove C, Van Snick J et al (2008) Transforming growth factor-beta “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9:1341–1346. doi:10.1038/ni.1659
38. Dardalhon V, Awasthi A, Kwon H et al (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells. Nat Immunol 9:1347–1355. doi:10.1038/ni.1677
39. Chang H-C, Sehra S, Goswami R et al (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11:527–534. doi:10.1038/ni.1867
40. Staudt V, Bothur E, Klein M et al (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33:192–202. doi:10.1016/j.immuni.2010.07.014
41. Horka H, Staudt V, Klein M et al (2012) The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J Immunol 188:2669–2676. doi:10.4049/jimmunol.1100529
42. Kaplan MH, Hufford MM, Olson MR (2015) The development and in vivo function of T helper 9 cells. Nat Rev Immunol. doi:10.1038/nri3824
43. Purwar R, Schlapbach C, Xiao S et al (2012) Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18:1248–1253. doi:10.1038/nm.2856
44. Lu Y, Hong S, Li H et al (2012) Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122:4160–4171. doi:10.1172/JCI65459